start
bluetongu
viru
serotyp
respons
major
epizoot
western
northern
europ
magnitud
spread
diseas
surprisingli
high
control
btv
improv
significantli
market
inactiv
vaccin
late
summer
first
cluster
reduc
milk
yield
fever
diarrhoea
report
netherland
congenit
malform
appear
march
schmallenberg
viru
sbv
identifi
becom
one
orthobunyavirus
distribut
europ
start
epizoot
littl
known
pathogenesi
epidemiolog
virus
european
context
assumpt
extrapol
base
relat
virus
andor
region
world
standard
repeat
model
potenti
mimick
clinic
sign
observ
field
requir
studi
pathogenesi
infect
clarifi
abil
cross
placent
barrier
review
present
latest
experiment
design
infecti
diseas
challeng
btv
sbv
infecti
dose
rout
infect
inoculum
prepar
origin
discuss
particular
emphasi
given
placent
cross
associ
two
virus
amongst
pathogen
rna
virus
major
sourc
emerg
diseas
last
year
high
mutat
rate
case
segment
genom
reassort
respons
genet
adapt
variabl
virus
two
pathogen
affect
cattl
sheep
respons
major
outbreak
mainland
europ
past
year
bluetongu
viru
btv
schmallenberg
viru
sbv
outbreak
singular
sever
way
diseas
previous
either
never
report
northern
locat
bluetongu
viru
recent
discov
schmallenberg
viru
emerg
still
high
qualiti
infecti
inoculum
reproduc
pathogenesi
diseas
essenti
investig
vaccin
efficaci
requir
certain
specif
aspect
pathogenesi
recent
discov
virus
face
emerg
diseas
epizoot
potenti
reproduct
clinic
diseas
experiment
condit
might
reliabl
use
infecti
anim
product
blood
serum
nevertheless
appear
major
recent
experiment
infect
involv
btv
sbv
cell
cultur
grown
inocula
prefer
challeng
tabl
reason
use
cellpassag
virus
summar
follow
origin
isol
strain
particular
interest
ship
almost
anywher
world
lead
great
improv
standard
viral
amplif
cellpassag
allow
high
increas
viral
titr
subsequ
allow
inocul
lower
volum
screen
contamin
pathogen
easier
cell
cultur
elimin
veterinari
public
health
concern
use
rumin
blood
infect
rumin
virul
cell
cultur
easili
standard
tabl
inocula
characterist
use
recent
experiment
infect
studi
btv
sbv
search
pubm
juli
keyword
experiment
infect
bluetongu
experiment
infect
schmallenberg
articl
experiment
infect
involv
least
one
rumin
speci
among
cattl
sheep
goat
retain
number
infect
anim
take
account
actual
infect
one
exclud
control
anim
sever
recent
studi
clinic
sign
report
btv
infect
anim
lesser
extent
report
field
modifi
live
vaccin
gain
attenu
serial
cell
passag
first
obviou
hypothesi
explain
mild
sever
bluetongu
diseas
experi
use
cultur
grown
viru
moreov
passag
histori
inocula
use
involv
mostli
embryon
chicken
egg
ece
vero
cell
report
btv
grown
kc
cell
deriv
culicoid
sonorensi
could
induc
greater
clinic
sign
sever
probabl
kc
cell
better
mimic
natur
vectorborn
infect
compar
viru
passag
cell
line
like
famili
rna
virus
peribunyaviridaernadepend
rna
polymeras
orbivirus
rnadepend
rna
polymeras
prone
produc
error
viral
genom
replic
gener
rna
viru
replic
character
high
mutat
rate
misincorpor
per
nucleotid
copi
short
gener
time
high
progeni
yield
addit
segment
rna
virus
also
gener
genom
variat
recombin
reassort
therefor
rna
virus
form
popul
close
relat
viral
variant
start
singl
clone
quasispeci
arthropod
vector
sbv
btv
typic
undergo
altern
twohost
life
cycl
therefor
suggest
stabl
evolv
slower
vectorindepend
virus
step
may
put
select
pressur
virus
remain
unknown
whether
sequenc
diverg
relat
mammalian
arthropod
portion
life
cycl
howev
demonstr
despit
lack
chang
consensu
sequenc
passag
btv
culicoid
cell
induc
increas
number
lowfrequ
variant
well
increas
virul
phenomenon
hypothes
explain
reduc
viraemia
clinic
pictur
seen
reemerg
versu
strain
matter
fact
also
report
inocul
infecti
materi
field
isol
rare
produc
clinic
pictur
sever
natur
infect
addit
hypothesi
would
culicoid
saliva
might
act
catalys
enhanc
abil
btv
produc
sever
clinic
sign
inde
culicoid
saliva
demonstr
contain
trypsinlik
proteas
abl
cleav
lead
infecti
subvir
particl
format
enhanc
infect
demonstr
suitabl
passag
time
cell
cultur
reproduc
clinic
sign
rna
detect
calv
author
conclud
benefit
culturegrown
virus
use
experiment
challeng
rumin
well
despit
converg
result
polici
oie
remain
unchang
regard
recommend
vaccin
efficaci
requir
ie
challeng
vaccin
unvaccin
sheep
viru
passag
rumin
anim
limit
ece
cell
cultur
passag
result
regard
sbv
show
much
consist
cattl
wernik
et
al
report
reduc
viral
replic
cell
culturegrown
sbv
compar
natur
hostpassag
inoculum
contrast
one
year
later
team
conclud
suitabl
infecti
serum
low
passag
cell
cultur
materi
sbv
experiment
challeng
sheep
addit
passag
histori
origin
isol
viru
seem
import
viru
origin
central
nervou
system
fail
reproduc
rnaemia
inocul
anim
success
serial
passag
cellcultur
usual
result
decreas
virul
howev
regard
sbv
varela
et
al
report
increas
pathogen
sbv
strain
passag
time
infincompet
sheep
cpttert
cell
associ
faster
spread
viru
brain
suckl
mice
sbv
demonstr
grow
effici
sever
cell
line
includ
sheep
cpttert
bovin
bfae
human
dog
mdck
hamster
bsr
kc
vero
cell
wherea
serial
passag
cpttert
led
accumul
varieti
mutat
mostli
segment
porcin
cell
line
prove
highli
suscept
allow
genet
stabil
sbv
throughout
success
passag
therefor
depend
cell
line
use
grow
sbv
serial
passag
lead
attenu
increas
virul
effici
propag
low
frequenc
nucleotid
exchang
come
arbovirus
choic
rout
inocul
driven
two
main
consider
need
rout
best
mimic
behaviour
vector
field
condit
usual
haematophag
arthropod
either
telmophag
solenophag
depend
vector
speci
rout
might
intraderm
id
subcutan
sc
intraven
iv
experiment
infect
inocul
viral
load
volum
usual
higher
one
inocul
natur
occur
feed
given
size
arthropod
size
mouthpart
anoth
drawback
alreadi
mention
lack
vector
saliva
compon
modifi
structur
infect
reovirida
peribunyavirida
viral
particl
need
rout
ensur
viru
reach
blood
stream
quit
obvious
intraven
rout
sinc
vector
saliva
compon
enhanc
infect
arbovirus
risk
inocul
viru
alon
distal
site
vector
feed
site
could
result
fail
infect
therefor
option
bypass
skin
reach
bloodstream
may
relev
sever
author
includ
us
use
mix
rout
overcom
respect
disadvantag
approach
tabl
studi
group
compar
intranas
intraderm
subcutan
rout
experiment
infect
ewe
sbv
intraderm
interest
yet
underus
rout
inde
haematophag
arthropod
pass
skin
mouthpart
allow
feed
intraderm
cellular
fluid
exchang
skin
blood
occur
dermi
addit
evid
suggest
intraderm
inocul
appropri
reproduc
mani
aspect
natur
infect
includ
clinic
diseas
viral
immun
respons
intraderm
rout
demonstr
better
mimic
natur
earli
stage
infect
directli
influenc
sever
diseas
btvinduc
immunosuppress
link
infect
disrupt
follicular
dendrit
cell
mostli
possibl
intraderm
inocul
howev
perform
actual
intraderm
inocul
volum
inject
limit
dermi
mostli
compos
dens
network
collagen
fibr
therefor
requir
multipli
inocul
site
reach
desir
total
inoculum
volum
infecti
titr
realiz
inocul
practic
tool
dermojet
akra
dermojet
special
syring
intraderm
inject
use
perform
bovin
tuberculosi
skin
test
exampl
devic
allow
usual
volum
ml
thu
need
multipl
inject
reach
common
ml
inocul
volum
use
rumin
infecti
challeng
experi
tabl
moreov
system
inoculum
transfer
origin
vial
small
tank
dermojet
special
cartridg
use
intraderm
syring
extra
step
increas
number
handl
limit
especi
case
pathogen
investig
intranas
rout
test
whether
potenti
direct
sbv
contamin
sheep
could
achiev
regard
btv
sever
author
report
unexpect
inconclus
direct
horizont
transmiss
differ
serotyp
least
sever
author
report
direct
link
inocul
viral
dose
onset
clinic
sign
viraemia
ie
higher
dose
sooner
clinic
sign
viral
rna
detect
anoth
studi
evalu
four
dilut
sbv
infecti
serum
inoculum
ewe
undilut
origin
inoculum
titr
tcid
ml
appear
critic
dose
inocul
reproduc
fieldlik
virolog
immunolog
paramet
threshold
reach
dosedepend
effect
anymor
success
infect
anim
statist
differ
differ
inocul
dose
found
durat
quantiti
viral
rna
circul
blood
amount
viral
rna
present
viru
posit
lymphoid
organ
likewis
di
gialleonardo
et
al
compar
three
group
cattl
inocul
dilut
signific
differ
viraemia
kinet
could
found
inocul
bite
culicoid
report
effici
intraderm
inocul
especi
delay
earli
immun
respons
host
despit
gener
lower
inocul
viral
dose
compar
needl
inocul
sever
mechan
hypothes
explain
appar
enhanc
infect
culicoid
transmit
btv
culicoid
saliva
contain
proteas
abl
cleav
lead
format
infecti
subvir
particl
isvp
display
higher
infect
kc
cell
culicoid
ratio
infecti
btv
particl
versu
defect
virion
produc
within
culicoid
might
higher
compar
cell
cultur
grown
btv
pharmacolog
agent
contain
culicoid
saliva
might
affect
host
immun
respons
antiprolif
effect
leucocyt
reduc
inf
alphabeta
express
demonstr
vesicular
stomat
viru
mosquito
saliva
nonetheless
use
culicoid
perform
experiment
challeng
remain
highli
limit
practic
constraint
date
besid
c
nubeculosu
c
riethi
c
sonorensi
culicoid
speci
success
establish
labadapt
coloni
altern
insect
caught
wild
addit
prior
infecti
challeng
rumin
host
infect
culicoid
particularli
tricki
given
size
insect
exact
amount
viru
deliv
rumin
known
altogeth
subcutan
rout
seem
repres
best
compromis
btv
sbv
dose
suffici
gain
use
massiv
viral
load
bluetongu
diseas
histori
scar
incid
contamin
biolog
sampl
modifi
live
vaccin
canin
distemp
canin
adenoviru
type
canin
parainfluenza
canin
parvoviru
reconstitut
kill
canin
coronaviru
vaccin
led
abort
sever
bitch
viru
could
isol
eventu
identifi
btv
serotyp
recent
case
contamin
report
ans
agenc
national
de
sanitair
de
laliment
de
lenvironn
et
du
travail
maisonalfort
franc
context
experiment
infect
goat
appear
close
relat
isol
belgium
discuss
contamin
recent
studi
particular
inoculum
previous
involv
two
experiment
infect
eschbaum
et
al
use
cultur
supernat
passag
vero
cell
inject
calv
sheep
inoculum
subsequ
use
dal
pozzo
et
al
exact
outcom
name
discoveri
contamin
btv
inoculum
contamin
btv
heterolog
serotyp
rasmussen
et
al
report
use
inoculum
contamin
border
diseas
viru
sheep
far
literatur
report
experiment
infect
sbv
inoculum
contamin
anoth
viru
belong
differ
famili
broadli
speak
contamin
rout
like
relat
laboratori
contamin
sampl
prepar
ii
natur
multipl
infect
origin
donor
anim
given
potenti
dramat
consequ
contamin
incid
inocula
test
major
pathogen
affect
host
speci
use
challeng
experi
also
set
btv
serotyp
consid
risk
despit
transient
circul
vaccin
origin
europ
contamin
mention
happen
similar
refer
strain
henc
contamin
inoculum
far
necessarili
relat
ongo
viral
circul
even
though
might
remain
silent
lack
clinic
consequ
thu
rule
potenti
btv
contamin
known
btv
serotyp
test
recommend
would
inevit
increas
constraint
cost
qualiti
control
inocula
prior
use
experiment
infect
extens
screen
could
howev
consid
casebycas
basi
vertic
transmiss
pregnant
dam
offspr
one
major
consequ
sbv
btv
mani
pathogen
abl
cross
placenta
caus
foetal
injuri
matern
viru
infect
transmit
foetu
howev
certain
virus
abl
cross
placent
barrier
possibl
caus
development
defect
teratogenesi
teratogenesi
product
perman
abnorm
structur
function
restrict
growth
death
embryo
foetu
outcom
utero
infect
depend
suscept
foetu
infect
viru
turn
reflect
gestat
age
foetu
exposur
well
virul
characterist
infect
viru
nervou
tissu
import
target
btv
sbv
usual
younger
foetu
sever
lesion
colon
foetu
virus
need
way
therefor
consid
sbv
utero
infect
occur
first
placentom
establish
around
day
pregnanc
cattl
slightli
earlier
sheep
implant
sever
chang
occur
papilla
uterin
gland
immobil
conceptu
start
elong
cattl
day
post
coitum
dpc
sheep
dpc
subsequ
cell
trophectoderm
uterin
epithelium
get
interdigit
binucl
cell
start
seen
binucl
cell
start
differenti
migrat
cattl
dpc
sheep
dpc
foetal
villi
develop
caruncular
area
start
dpc
small
rumin
dpc
cattl
thu
defin
end
implant
start
placent
develop
tabl
summar
essenti
event
cours
prenat
develop
cattl
sheep
recent
studi
decid
infect
vaccin
nonvaccin
pregnant
heifer
day
pregnanc
btv
pregnant
heifer
studi
also
challeng
pregnant
ewe
sbv
day
pregnanc
sbv
pregnant
ewe
studi
thu
virus
experiment
infect
took
place
within
critic
timefram
day
cattl
day
pregnanc
sheep
figur
moreov
experiment
condit
frequent
btv
transplacent
infect
report
occur
midterm
gestat
around
day
pregnanc
sheep
prenat
period
divid
four
main
period
fertil
ii
blastogenesi
iii
embryogenesi
iv
foetogenesi
embryo
develop
tissu
organ
structur
three
origin
germ
layer
ecto
meso
endoderm
organ
differenti
embryo
becom
foetu
foetal
phase
character
fast
growth
conceptu
cattl
sheep
foetogenesi
start
around
dpc
respect
thu
critic
timefram
btv
sbv
infect
overlap
end
embryo
stage
begin
foetal
stage
moreov
although
rumin
gamma
globulin
unabl
go
placent
barrier
mother
foetu
admit
cow
sheep
foetus
becom
sequenti
increasingli
immunocompet
larger
varieti
antigen
throughout
pregnanc
critic
timefram
btv
sbv
infect
also
span
cours
sever
import
event
immun
system
develop
tabl
although
sequenc
antigen
success
progress
recogn
foetal
rumin
pregnanc
seem
quit
conserv
individu
antigen
recogn
start
differ
day
individu
individu
variabl
could
explain
find
de
clercq
et
al
report
possibl
combin
serolog
statusrtqpcr
result
damcalf
pair
context
high
suspicion
along
result
interpret
appar
immunotoler
likewis
malform
calv
lamb
report
sbv
viroposit
vironeg
without
sbv
antibodi
suggest
possibl
utero
clearanc
viru
moreov
malform
calv
neg
sbv
antibodi
rtqpcr
born
seroposit
mother
studi
none
evoc
lesion
report
either
btv
pregnant
heifer
studi
sbv
pregnant
ewe
studi
follow
infect
pregnant
dam
report
redden
muzzl
haemorrhag
wall
pulmonari
arteri
calv
born
nonvaccin
mother
haemorrhag
pulmonari
arteri
btv
typic
yet
pathognomon
lesion
find
associ
absenc
antibtv
antibodi
prior
colostrum
intak
melzi
et
al
report
earli
infect
destruct
follicular
dendrit
cell
follow
btv
infect
consequ
antibodi
product
notabl
impair
could
element
explain
lack
btv
antibodi
detect
calv
result
provid
interest
perspect
mani
petechi
haemorrhag
observ
lymph
node
sever
experiment
infect
follow
infect
pregnant
ewe
sbv
bornal
lamb
none
antisbv
neutral
antibodi
prior
colostrum
intak
experi
time
inocul
optim
achiev
transplacent
infect
foetu
regard
data
avail
literatur
yet
malform
could
seen
antibodi
viru
use
infect
mother
could
detect
well
strike
result
might
even
question
success
infect
notwithstand
posit
rna
detect
mother
btv
pregnant
heifer
studi
report
similar
lesion
serolog
result
anoth
experi
goat
sbv
pregnant
ewe
studi
detect
sbv
nucleic
acid
organ
sever
lamb
mani
extraembryon
structur
provid
support
actual
transplacent
infect
addit
anoth
studi
manag
isol
sbv
foetal
envelop
anim
sbv
pregnant
ewe
studi
birth
thu
day
post
infect
low
ratio
precolostr
seroconvers
immunocompet
foetus
also
report
follow
infect
pregnant
cattl
sbv
transplacent
transmiss
base
field
data
report
rang
experiment
infect
passag
mother
foetu
could
demonstr
infect
ewe
wherea
could
detect
foetu
highest
suscept
could
observ
around
day
pregnanc
sheep
infect
day
report
result
much
lighter
consequ
placent
cross
depend
gestat
stage
btv
serotyp
inocul
dose
report
caus
congenit
defect
offspr
infect
ewe
author
observ
vertic
transmiss
rate
goat
infect
day
pregnanc
btv
epizoot
darpel
et
al
estim
transplacent
infect
rate
consist
latter
result
lesion
potenti
present
calv
affect
utero
sbv
could
distinguish
accord
two
entiti
hydrocephalyhydranencephali
syndrom
torticollisarthrogryposi
syndrom
analog
akaban
viru
infect
first
month
seem
critic
infect
foetu
day
usual
give
rise
hydranencephalyporencephali
type
lesion
predominantli
arthrogryposi
latest
lesion
observ
infect
day
gestat
appear
foetus
less
two
month
old
concept
could
protect
utero
infect
contrast
sbv
torticolli
hardli
seen
utero
infect
btv
epidem
domin
hydranencephali
sheep
also
contrast
sbv
btv
utero
infect
vast
major
case
associ
btv
lab
adapt
strain
ie
passag
cell
cultur
like
modifi
live
vaccin
strain
recent
european
wild
type
viru
end
centuri
least
five
btv
serotyp
modifi
live
vaccin
origin
report
abl
cross
placent
barrier
possibl
caus
teratogen
effect
utero
infect
caus
wildtyp
strain
consid
uncommon
yet
document
sbv
vertic
transmiss
seem
lower
compar
btv
especi
cattl
rate
malform
caus
sbv
report
cattl
although
rate
intrauterin
infectionbas
serolog
result
calv
prior
colostrum
intakewa
report
author
document
field
data
congenit
malform
affect
calv
lamb
farm
begin
sbv
epizoot
belgium
base
survey
target
farmer
also
found
estim
malform
sheep
sbv
posit
flock
tabl
summar
common
utero
malform
nervou
lesion
induc
common
virus
induc
btv
sbvlike
lesion
rumin
utero
potenti
btv
blue
shade
sbv
induc
defect
green
shade
follow
infect
pregnant
dam
along
whole
gestat
time
cattl
small
rumin
time
express
fraction
total
gestat
time
detail
timelin
avail
supplementari
file
utero
potenti
btv
blue
shade
sbv
induc
defect
green
shade
follow
infect
pregnant
dam
along
whole
gestat
time
cattl
small
rumin
time
express
fraction
total
gestat
time
detail
timelin
avail
supplementari
file
embryon
loss
repres
key
factor
affect
rumin
product
system
cattl
well
sheep
spontan
embryo
mortal
occur
earli
embryon
life
name
dpc
cattl
earli
embryon
loss
normal
condit
report
rang
wherea
sheep
rang
clear
increas
embryo
death
ovul
rate
impact
btv
sbv
reproduct
paramet
teratogenesi
well
document
report
increas
servic
rate
number
ai
artifici
insemin
requir
achiev
pregnanc
sbv
epizoot
number
ai
get
cattl
pregnant
slightli
yet
significantli
increas
regardless
whether
part
herd
report
malform
indic
actual
infect
although
sbv
especi
btv
tremend
econom
impact
livestock
industri
worthwhil
highlight
rel
poor
effici
placent
cross
specif
overal
low
rate
congenit
deform
induc
virus
howev
congenit
malform
underestim
actual
rate
btv
sbv
transplacent
infect
number
rumin
use
experiment
infect
chosen
base
welfar
statist
concern
also
quit
unfortun
econom
practic
ground
perform
experiment
infect
btv
facil
sciensano
ukkel
belgium
sbv
facil
depend
phase
experi
inde
belgian
servic
biosafeti
biotechnolog
well
belgian
law
classifi
btv
class
pathogen
wherea
recommend
sbv
biosafeti
measur
sbv
base
analog
akav
also
classifi
class
pathogen
domest
rumin
herd
anim
need
hous
group
least
individu
euthanasia
method
human
possibl
clear
end
point
defin
given
scarciti
clinic
sign
caus
btv
sbv
field
individu
variat
respons
infect
number
anim
includ
chosen
care
compli
reduct
object
three
rs
concept
suffici
limit
risk
abl
provid
use
data
context
ongo
scientif
investig
particularli
difficult
experiment
infect
pregnant
rumin
low
malform
rate
follow
transplacent
transmiss
object
paramet
assess
vaccin
efficaci
viru
especi
rna
vectorborn
viru
evalu
viral
rna
detect
rtqpcr
host
target
btv
sbv
virul
demonstr
vari
depend
rumin
host
whether
cattl
sheep
goat
addit
pregnanc
length
differ
cattl
small
rumin
placent
develop
foetal
envelop
present
slight
differ
consequ
studi
specif
aspect
relat
rumin
speci
anim
model
altern
abl
mimic
natur
situat
proper
way
result
present
latest
studi
provid
new
insight
virus
spread
europ
caus
sever
loss
livestock
industri
addit
aspect
open
new
perspect
expand
knowledg
emerg
vectorborn
virus
target
rumin
specif
accord
experi
subcutan
rout
inoculum
passag
limit
number
time
cell
cultur
seem
repres
best
compromis
high
probabl
reproduc
infect
similar
happen
field
logist
concern
preparationstoragemanag
inoculum
prevent
loss
viral
variabl
limit
risk
attenu
isol
btv
could
done
kc
cell
wherea
sbv
could
benefit
isol
highli
suscept
cell
line
screen
concomit
pathogen
consid
case
case
basi
requir
dose
chosen
base
literatur
data
yet
advantag
provid
inocul
massiv
viral
load
sinc
data
author
suggest
better
reproduct
diseas
intraderm
inocul
could
investig
especi
userfriendli
devic
would
avail
major
breakthrough
would
success
adapt
coloni
palearct
btv
sbv
vector
culicoid
speci
c
obsoletusscoticu
pulicari
laboratori
condit
subsequ
use
infecti
challeng
vectorborn
transmiss
btv
impli
punctur
skin
point
grow
evid
certain
circumst
addit
rout
transmiss
observ
goat
report
infect
without
direct
contact
recent
discov
also
display
abil
infect
goat
direct
contact
experiment
infect
control
ewe
found
posit
studi
viru
factor
affect
modifiedunderreport
transmiss
featur
allow
better
understand
epidemiolog
diseas
conclus
target
rumin
host
speci
experiment
infect
especi
culicoid
born
pathogen
expens
time
consum
subject
stringent
anim
welfar
constraint
critic
sampl
size
analysi
meet
optim
statist
requir
howev
rumin
model
remain
unavoid
assess
diseas
impact
studi
pathogenesi
emerg
vectorborn
virus
supplementari
materi
follow
avail
onlin
http
figur
schemat
suggest
timefram
sbv
btv
b
utero
infect
caus
defect
cattl
small
rumin
offspr
author
contribut
lm
cs
fdp
conceiv
review
lm
wrote
review
paper
cs
fdp
kdc
et
review
articl
graff
sophi
kdc
improv
english
author
read
approv
final
manuscript
fund
fund
feder
public
servic
health
food
chain
safeti
environ
contract
rf
contract
rt
bluetongu
contract
rt
contract
rf
brussel
belgium
fond
pour
la
recherch
de
contract
univers
belgium
fond
pour
la
recherch
gro
contract
univers
belgium
frsfnr
frfc
grant
european
union
outlin
council
decis
concern
financi
contribut
union
studi
schmallenberg
viru
funder
role
studi
design
data
collect
analysi
decis
publish
prepar
manuscript
author
declar
compet
interest
